Drug Type Monoclonal antibody |
Synonyms AMG 430 |
Target |
Mechanism Protein jagged-1 modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cystic Fibrosis | Phase 1 | US | 29 Aug 2019 | |
Pulmonary Disease, Chronic Obstructive | Phase 1 | US | 20 Jul 2019 |